Skip to main content
Clinical Trials/NCT06056544
NCT06056544
Enrolling By Invitation
Not Applicable

A Randomized Clinical Trial of Client-centered Care Coordination to Improve Preexposure Prophylaxis Use for Black Men Who Have Sex With Men

University of Maryland, Baltimore2 sites in 1 country350 target enrollmentDecember 21, 2025

Overview

Phase
Not Applicable
Intervention
Client Centered Care Coordination
Conditions
HIV Prevention
Sponsor
University of Maryland, Baltimore
Enrollment
350
Locations
2
Primary Endpoint
PrEP Adherence
Status
Enrolling By Invitation
Last Updated
yesterday

Overview

Brief Summary

The goal of this clinical trial is to determine the efficacy of a client-center care coordination intervention (C4) in improving pre-exposure prophylaxis (PrEP) adherence in Black men who have sex with men (MSM). The main aims of the study are:

  1. Determine the efficacy of C4 for increasing PrEP adherence among Black MSM.
  2. Identify the optimal dose of C4 implementation for maximizing its effect on PrEP adherence.
  3. Describe the acceptability and feasibility of C4 implementation in community settings.

Participants in the clinical trial will be randomized to receive the intervention or standard of care for PrEP in two sites. Researchers will compare administration of C4 to standard of care to see if C4 improves adherence to PrEP. C4 is a longitudinal intervention which provides individualized client-centered HIV prevention and support services designed to address health and psychosocial needs that impact the success of PrEP use and adherence (i.e., co-morbidities, substance use, mental health, housing, etc.). The intervention pulls from the Centers for Disease Control and Prevention (CDC) Comprehensive Risk Counseling and Services (CRCS) and Self-Determination Theory (SDT) to support client-identified HIV prevention goals to promote, adopt, and maintain PrEP use. CRCS is a public health strategy to assist persons in developing behavioral goals to reduce HIV acquisition and transmission. In this intervention, the HIV prevention plan element of CRCS will be the foundation of the C4 intervention. After the initial prevention plan is developed, elements of SDT will be used to implement a client-centered care approach to assist in addressing issues which many arise which impede successful PrEP adherence.

Registry
clinicaltrials.gov
Start Date
December 21, 2025
End Date
August 1, 2028
Last Updated
yesterday
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Darren L Whitfield

Associate Professor

University of Maryland, Baltimore

Eligibility Criteria

Inclusion Criteria

  • Age of 18 years of age
  • Identify as Black, African American, Black African, Afro-Caribbean, or Black-Latino
  • Cisgender male
  • PrEP naïve or who prematurely stopped PrEP
  • No prior HIV diagnosis confirmed through HIV testing
  • Self-reported high risk for acquiring HIV
  • Currently not enrolled in another HIV prevention study

Exclusion Criteria

  • Black MSM who received a reactive or positive HIV test at screening or self report HIV-positive
  • Identifying as transgender
  • Current participation in any research study via self-report
  • Use of PrEP or post-exposure prophylaxis in the last 60 days prior to anticipated enrollment

Arms & Interventions

Intervention Group

C4 is a longitudinal intervention which provides individualized client-centered HIV prevention and support services designed to address health and psychosocial needs that impact the success of PrEP use and adherence (i.e., co-morbidities, substance use, mental health, housing, etc.).

Intervention: Client Centered Care Coordination

Control Group

Individuals in the control group will receive standard of care for PrEP use at each clinic. The standard of care is PrEP clinical care includes identifying and engaging patients in need of PrEP, conducting necessary exams and lab tests and prescribing PrEP for the patients, as well as ongoing patient monitoring with follow-up visits and prescriptions-for as long as the patient needs PrEP.

Outcomes

Primary Outcomes

PrEP Adherence

Time Frame: 6, 12, 18 months

Count of doses of PrEP missed in the last 30 days by self report

Study Sites (2)

Loading locations...

Similar Trials